Prudential Financial’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.2K | Sell |
15,700
-16,490
| -51% | -$14.9K | ﹤0.01% | 2412 |
|
|
2025
Q1 | $14.5K | Buy |
32,190
+13,200
| +70% | +$5.96K | ﹤0.01% | 2274 |
|
|
2024
Q4 | $9.54K | Buy |
+18,990
| New | +$9.54K | ﹤0.01% | 2280 |
|
|
2022
Q2 | – | Sell |
-10,485
| Closed | -$16K | – | 2717 |
|
|
2022
Q1 | $16K | Hold |
10,485
| – | – | ﹤0.01% | 2588 |
|
|
2021
Q4 | $26K | Sell |
10,485
-815
| -7% | -$2.02K | ﹤0.01% | 2611 |
|
|
2021
Q3 | $28K | Buy |
+11,300
| New | +$28K | ﹤0.01% | 2571 |
|
|
2020
Q1 | – | Sell |
-19,698
| Closed | -$18K | – | 2405 |
|
|
2019
Q4 | $18K | Buy |
19,698
+2,366
| +14% | +$2.16K | ﹤0.01% | 2419 |
|
|
2019
Q3 | $17K | Hold |
17,332
| – | – | ﹤0.01% | 2401 |
|
|
2019
Q2 | $19K | Hold |
17,332
| – | – | ﹤0.01% | 2445 |
|
|
2019
Q1 | $23K | Buy |
17,332
+816
| +5% | +$1.08K | ﹤0.01% | 2419 |
|
|
2018
Q4 | $15K | Buy |
+16,516
| New | +$15K | ﹤0.01% | 2368 |
|